Gossamer Bio (GOSS) Current Assets (2022 - 2025)
Historic Current Assets for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $204.0 million.
- Gossamer Bio's Current Assets fell 4074.7% to $204.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.0 million, marking a year-over-year decrease of 4074.7%. This contributed to the annual value of $309.9 million for FY2024, which is 109.91% up from last year.
- Latest data reveals that Gossamer Bio reported Current Assets of $204.0 million as of Q3 2025, which was down 4074.7% from $235.9 million recorded in Q2 2025.
- Gossamer Bio's 5-year Current Assets high stood at $370.9 million for Q2 2024, and its period low was $173.4 million during Q2 2023.
- Over the past 4 years, Gossamer Bio's median Current Assets value was $275.5 million (recorded in 2025), while the average stood at $274.3 million.
- As far as peak fluctuations go, Gossamer Bio's Current Assets surged by 11392.98% in 2024, and later plummeted by 4074.7% in 2025.
- Over the past 4 years, Gossamer Bio's Current Assets (Quarter) stood at $261.9 million in 2022, then increased by 17.05% to $306.5 million in 2023, then rose by 1.1% to $309.9 million in 2024, then crashed by 34.17% to $204.0 million in 2025.
- Its Current Assets was $204.0 million in Q3 2025, compared to $235.9 million in Q2 2025 and $275.5 million in Q1 2025.